...
首页> 外文期刊>Stroke: A Journal of Cerebral Circulation >MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization.
【24h】

MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization.

机译:基于MRI的动脉内卒中治疗选择:在选择将受益于早期再通的急性卒中患者中,治疗前扩散加权成像病变体积的价值。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND AND PURPOSE: Recent studies demonstrate that an acute diffusion-weighted imaging lesion volume >70 cm(3) predicts poor outcome in patients with stroke. We sought to determine if this threshold could identify patients treated with intra-arterial therapy who would do poorly despite reperfusion. In patients with initial infarcts <70 cm(3), we sought to determine what effect recanalization and time to recanalization had on infarct growth and functional outcome. METHODS: We retrospectively studied 34 consecutive patients with anterior circulation stroke who underwent pretreatment diffusion-weighted imaging and perfusion-weighted imaging and subsequent intra-arterial therapy. Recanalization success and time to recanalization were recorded. Initial diffusion-weighted imaging and mean transit time lesion and final infarct volumes were determined. Patients were stratified based on initial infarct volume, recanalization status, and time to recanalization. Statistical tests were performed to assess differences in clinical and imaging outcomes. Good clinical outcome was defined as a 3-month modified Rankin Scale score 70 cm(3), all had poor outcomes despite a 50% recanalization rate with mean infarct growth of 114 cm(3). These patients also had the largest mean transit time volumes (P<0.04). Patients with initial infarct volumes <70 cm(3) who recanalized early had the best clinical outcomes (P<0.008) with a 64% rate of modified Rankin Scale score
机译:背景与目的:最近的研究表明,急性弥散加权成像病变体积> 70 cm(3)预测中风患者的预后较差。我们试图确定该阈值是否可以识别接受动脉内治疗的患者,尽管再灌注仍然表现不佳。在初发梗死<70 cm(3)的患者中,我们试图确定再通和再通时间对梗塞生长和功能预后有什么影响。方法:我们回顾性研究了34例连续的前循环卒中患者,这些患者接受了预处理扩散加权成像和灌注加权成像以及随后的动脉内治疗。记录再通成功率和再通时间。确定了初始弥散加权成像,平均转移时间病变和最终梗死体积。根据初始梗死体积,再通状态和再通时间对患者进行分层。进行统计测试以评估临床和影像学结果的差异。良好的临床结果被定义为3个月修正兰金量表评分<或= 2。结果:在初始梗死> 70 cm(3)的患者中,尽管再通率达到50%,平均梗塞增长114 cm(3),但所有患者的预后均较差。这些患者的平均通过时间也最大(P <0.04)。初期再梗死的初始梗死体积<70 cm(3)的患者,其临床结局最佳(P <0.008),改良兰金评分评分≥64的比率为64%,平均梗塞最少(P <0.03)生长18厘米(3)。结论:这项研究支持使用急性弥散加权成像病变体积阈值作为动脉内治疗的成像选择标准。它还证实了在选定患者中早期再灌注的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号